30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Charles Conover

Insider profile

Performance

Overall performance
1.6

Performance over holding periods
1.6
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Senior Vice President - Research & Development, Program Management Enzon Pharmaceuticals Inc Jan. 1, 2012 - March 1, 2013
Vice President - Program Management and Compliance Enzon Pharmaceuticals Inc Jan. 1, 2011 - Jan. 1, 2012

Charles Conover's trades of Enzon Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2012-06-06 2012-06-05 S Sale
83,586 +18.2%
252.58
US$1,309,445
83,586 +18.2% 252.58 US$1,309,445